ENZO BIOCHEM INC 3 SEC Filings

Filed On	Filing
02 Dec 2024	Form 3: Couchman Jonathan, Director Holds 130,000 shares of Common Stock
30 Oct 2023	Form 3: Pully Steven J, Director No securities owned
09 Jan 2023	Form 3: Wolf James G., 10% owner Holds 3,560,000 shares of Common Stock, $0.01 par value
15 Nov 2022	Form 3: Eckert Patricia, Interim CFO Holds 11,392 shares of Common Stock, $0.01 Par Value
28 Mar 2022	Form 3: Cannon Kara, Chief Operating Officer Holds 22,614 shares of Common Stock, $0.01 Par Value
10 Jan 2022	Form 3: Radoff Bradley Louis, Director Holds 3,898,100 shares of Common Stock
10 Nov 2021	Form 3: Erfanian Hamid, Chief Executive Officer No securities owned
03 Dec 2020	Form 3: Walters Ian B., Director No securities owned
23 Nov 2020	Form 3: Tagliaferri Mary, Director No securities owned
14 Feb 2020	Form 3: Clemens Peter J Iv, 10% owner Holds 5,000 shares of Common Stock, par value $0.01 per share
06 Jan 2020	Form 3: Fischer Rebecca J., Director No securities owned
02 Jan 2020	Form 3: Bench David, CHIEF FINANCIAL OFFICER No securities owned
25 Sep 2019	Form 3: Blank Fabian, 10% owner Holds 10,280 shares of Common Stock, par value $0.01 per share
22 May 2019	Form 3: Harbert Management Corp, 10% owner and 8 others Holds 5,053,087 shares of Common Stock, $0.01 par value
13 Jan 2017	Form 3: Hanna Bruce A., Director
29 Jan 2015	Form 3: O'Brien James Michael, SVP of Finance
17 Sep 2012	Form 3: Perlysky Dov, Director Holds 19,964 shares of Common Stock
03 Jun 2011	Form 3: Whiteley Andrew P, VP BusDev-COO Enzo Lif Sci Inc Holds 15,000 shares of Common Stock
10 Feb 2010	Form 3: Bortz Gregory M., Director No securities owned
12 Mar 2009	Form 3: Krenitsky Kevin, President, Enzo Clinical Labs

Comments